2013年中国药理学发展研究:国际论文分析  

2013 Report on pharmacology in China: international article analysis

作　　者：穆鑫[1,2] 赵颖[1,2] 阿丽塔[3] 李阳[3] 王昕[2,4] 唐小利[3] 杜冠华[1,2] 

机构地区：[1]中国医学科学院北京协和医学院药物研究所,北京100050 [2]中国药理学会,北京100050 [3]中国医学科学院医学信息研究所,北京100005 [4]北京大学医学部,北京100191

出　　处：《中国药理学通报》2014年第5期593-596,共4页Chinese Pharmacological Bulletin

基　　金：国家科技部"重大新药创制"科技重大专项(No 2013ZX09102106);中国科学技术协会学会能力提升专项-优秀科技社团奖

摘　　要：为了解2013年中国药理学发展的特点,本文对中国学者2013年发表的国际论文进行研究,以期帮助科研人员了解该领域最新进展。本研究在2012版期刊引证报告自然科学版药理学期刊中,检索2013年中国学者发文情况。结果显示,2013年中国作者共参与发表文献5 090篇,其中,中国作者为第一/通讯作者的文献4 812篇,期刊影响因子最高为22.345。发文涉及的研究机构大多为大学和高校,科研院所及临床医院较少。从发表文章的数量上看,植物药研究在我国研究人员研究领域中占有重要地位,研究热点比较分散。结果提示,2013年我国药理学研究正处于发展的重要阶段,基础研究需要积累和创新,临床药理学和新药研究亟待加强。Aim To investigate the characteristics of research status of pharmacology in China and help Chinese scientists have a good look at latest development in this field, by analyzing the articles published in international journals in 2013. Methods Articles with Chinese authors published in pharmacology related international journals originating from the 2012 edition of natural science edition of Journal Citation Reports were retrieved. Results There were 5090 articles with Chinese authors published in 2013, including 4812 articles whose Chinese authors were the first author or corresponding author. Among them, the highest impact factor was 22. 345. Universities and colleges were the main organizations in paper publishment in China. The number of articles from research institutes and hospitals was much lower. Herbal medicine occupied a very important position in Chinese pharmacological research, while the research hotspot was scattered. Conclusion In 2013, the pharmacological research in China is at an important stage of development. A long continuous accumulation of summary and innovation is needed in basic research. More studies should focus on clinical pharmacology and drug discovery.

关 键 词：药理学 学科发展 国际论文 研究机构分析 研究领域分析 研究现状 

分 类 号：R-05[医药卫生] R-533